Currently, Hims & Hers Health Inc [HIMS] is trading at $45.1, down -2.00%. One of the good ways to gauge the recent performance is if the stock’s short-term value is rising or falling. The HIMS shares have lost -9.76% over the last week, with a monthly amount drifted -10.48%, and not seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Hims & Hers Health Inc [NYSE: HIMS] stock has seen the most recent analyst activity on June 23, 2025, when Needham downgraded its rating to a Hold. Previously, Needham reaffirmed its Buy rating on June 04, 2025, and elevated its price target to $65. On April 29, 2025, downgrade downgraded it’s rating to Hold but maintained its price target of $30 on the stock. Morgan Stanley downgraded its rating to a Equal-Weight and increased its price target to $60 on February 18, 2025. Citigroup downgraded its rating to a Sell and raised its price target to $25 on January 10, 2025. BTIG Research started tracking with a Buy rating for this stock on January 07, 2025, and assigned it a price target of $35. In a note dated December 17, 2024, Morgan Stanley initiated an Overweight rating and provided a target price of $42 on this stock.
This stock has fluctuated between a low of $13.47 and a high of $72.98 over the last 52 weeks. Currently, Wall Street analysts expect the stock to reach $52 within the next 12 months. Hims & Hers Health Inc [NYSE: HIMS] shares were valued at $45.1 at the most recent close of the market. An investor can expect a potential return of 15.3% based on the average HIMS price forecast.
Analyzing the HIMS fundamentals
Trailing Twelve Months sales for Hims & Hers Health Inc [NYSE:HIMS] were 2.01B which represents 72.61% growth. Gross Profit Margin for this corporation currently stands at 0.76% with Operating Profit Margin at 0.06%, Pretax Profit Margin comes in at 0.07%, and Net Profit Margin reading is 0.1%. To continue investigating profitability, this company’s Return on Assets is posted at 0.1, Equity is 0.38 and Total Capital is 0.08. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 1.86.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 44.51 points at the first support level, and at 43.93 for the second support level. However, for the 1st resistance point, the stock is sitting at 45.72, and for the 2nd resistance point, it is at 46.34.
Ratios To Look Out For
To put it in perspective, the Current Ratio for Hims & Hers Health Inc [NYSE:HIMS] is 4.98. Also, the Quick Ratio is 4.46, while the Cash Ratio stands at 4.13. Considering the valuation of this stock, the price to sales ratio is 5.06, the price to book ratio is 18.09 and price to earnings (TTM) ratio is 56.45.
Transactions by insiders
Recent insider trading involved Dudum Andrew, Officer, that happened on Aug 18 ’25 when 47534.0 shares were purchased. Officer, Dudum Andrew completed a deal on Aug 18 ’25 to buy 0.13 million shares. Meanwhile, Chief Financial Officer Okupe Oluyemi sold 11581.0 shares on Aug 13 ’25.
